Concepedia

Michelle Taylor

MT

Statistics

Publications

30

Citations

1.5K

H-Index

22

Active since

1992

Affiliations

University of North Texas(Current)

University of North Texas Health Science Center

Mallinckrodt (United States)

Washington University in St. Louis

National Institute on Drug Abuse

Michelle Taylor is an author at University of North Texas specializing in pharmacology, dopaminergic pharmacology, and medicinal chemistry.

Publications per year

1992–2023

30

Publications

30

Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation

Pavan Bhargava, Matthew D. Smith, Leah Mische et al. · Journal of Clinical Investigation · 2020 · 225 citations · Full text

, , +17

Novel Heterocyclic Trans Olefin Analogues of <i>N</i>-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as Selective Probes with High Affinity for the Dopamine D3 Receptor

Peter Grundt, Erin E. Carlson, Jianjing Cao et al. · Journal of Medicinal Chemistry · 2005 · 123 citations · Full text

, , +17

Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands

Wenhua Chu, Zhude Tu, Elizabeth McElveen et al. · Bioorganic & Medicinal Chemistry · 2004 · 105 citations

, , +15

Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation

Marjan Gharagozloo, Matthew D. Smith, Jing Jin et al. · Acta Neuropathologica · 2021 · 96 citations · Full text

, , +12

Heterocyclic Analogues of<i>N</i>-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with Functionalized Linking Chains as Novel Dopamine D3 Receptor Ligands:  Potential Substance Abuse Therapeutic Agents

Peter Grundt, Katherine M. Prevatt, Jianjing Cao et al. · Journal of Medicinal Chemistry · 2007 · 89 citations · Full text

, , +17

1–5 of 30